A

Aditxt
D

ADTX

0.38500
USD
0.05
(13.27%)
Market Closed
Volume
65,271
EPS
-91
Div Yield
-
P/E
-0
Market Cap
5,480,171
OverviewSignalsIdeasNews
Related Instruments
    A
    ADCT
    -0.27000
    (-10.19%)
    2.38000 USD
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    APT
    0.07000
    (1.34%)
    5.30000 USD
    C
    CDTX
    -0.220
    (-1.49%)
    14.500 USD
    C
    CODX
    -0.04000
    (-3.64%)
    1.06000 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    V
    VIR
    -0.63500
    (-7.35%)
    8.01000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: Aditxt Inc

Sector: Healthcare
Industry: Biotechnology
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.